01.01.2014 | Letter to the Editor
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation
Erschienen in: Annals of Hematology | Ausgabe 1/2014
Einloggen, um Zugang zu erhalten